Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Alda

Showing results (261-270 of 350) with videos related to

Pageof 35
Sort By:
The American Journal of Psychiatry|March 1, 2023
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected ParentsAlyson Zwicker, Janice M Fullerton, Niamh Mullins, et al.
International Journal of Bipolar Disorders|April 25, 2026
Lithium effects on renal functioning: an expert opinion and management algorithmCharlotte Strandhave, Hans August Stengaard Hansen, Martin Alda, et al.
Journal of Affective Disorders|November 23, 2025
Antidepressant use in older age bipolar disorder (OABD): Results from the GAGE-BD international consortiumChristina Rigas, Paola Lavin, P J Chen, et al.
Neuropsychobiology|May 11, 2010
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatmentThomas G Schulze, Martin Alda, Mazda Adli, et al.
Bipolar Disorders|November 26, 2021
Correction of depression-associated circadian rhythm abnormalities is associated with lithium response in bipolar disorderMonica Federoff, Michael J McCarthy, Amit Anand, et al.
Scientific Reports|January 14, 2021
Prediction of lithium response using genomic dataWilliam Stone, Abraham Nunes, Kazufumi Akiyama, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
The association between lithium use and neurocognitive performance in patients with bipolar disorderKatherine E Burdick, Caitlin E Millett, Manuela Russo, et al.
Molecular Psychiatry|February 19, 2026
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium studyAda Man-Choi Ho, Brandon J Coombes, Anthony Batzler, et al.
Bipolar Disorders|April 2, 2021
Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) studyYian Lin, Adam X Maihofer, Emma Stapp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2017
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesisBrian T D Tobe, Andrew M Crain, Alicia M Winquist, et al.
Pageof 35

Showing results (261-270 of 350) with videos related to

Sort By:
Pageof 35
The American Journal of Psychiatry|March 1, 2023
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected ParentsAlyson Zwicker, Janice M Fullerton, Niamh Mullins, et al.
International Journal of Bipolar Disorders|April 25, 2026
Lithium effects on renal functioning: an expert opinion and management algorithmCharlotte Strandhave, Hans August Stengaard Hansen, Martin Alda, et al.
Journal of Affective Disorders|November 23, 2025
Antidepressant use in older age bipolar disorder (OABD): Results from the GAGE-BD international consortiumChristina Rigas, Paola Lavin, P J Chen, et al.
Neuropsychobiology|May 11, 2010
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatmentThomas G Schulze, Martin Alda, Mazda Adli, et al.
Bipolar Disorders|November 26, 2021
Correction of depression-associated circadian rhythm abnormalities is associated with lithium response in bipolar disorderMonica Federoff, Michael J McCarthy, Amit Anand, et al.
Scientific Reports|January 14, 2021
Prediction of lithium response using genomic dataWilliam Stone, Abraham Nunes, Kazufumi Akiyama, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
The association between lithium use and neurocognitive performance in patients with bipolar disorderKatherine E Burdick, Caitlin E Millett, Manuela Russo, et al.
Molecular Psychiatry|February 19, 2026
Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium studyAda Man-Choi Ho, Brandon J Coombes, Anthony Batzler, et al.
Bipolar Disorders|April 2, 2021
Clinical predictors of non-response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) studyYian Lin, Adam X Maihofer, Emma Stapp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2017
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesisBrian T D Tobe, Andrew M Crain, Alicia M Winquist, et al.
Pageof 35